Beta Bionics, Inc.·4

Feb 3, 8:30 PM ET

Palasis Maria 4

4 · Beta Bionics, Inc. · Filed Feb 3, 2025

Insider Transaction Report

Form 4
Period: 2025-01-31
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-01-31+9,1379,137 total
    Exercise: $7.51Exp: 2033-01-24Common Stock (9,137 underlying)
Footnotes (2)
  • [F1]The shares subject to this option shall vest in 36 equal monthly installments measured from August 15, 2022.
  • [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.

Documents

1 file
  • 4
    form4-02032025_080215.xmlPrimary